What is the share price of Fischer Medical Ventures Ltd (FISCHER) today?
The share price of FISCHER as on 5th December 2025 is ₹45.92. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Fischer Medical Ventures Ltd (FISCHER) share?
The past returns of Fischer Medical Ventures Ltd (FISCHER) share are- Past 1 week: 3.46%
- Past 1 month: -55.60%
- Past 3 months: -57.00%
- Past 6 months: -39.58%
- Past 1 year: -39.58%
- Past 3 years: N/A%
- Past 5 years: -39.58%
What are the peers or stocks similar to Fischer Medical Ventures Ltd (FISCHER)?
The peers or stocks similar to Fischer Medical Ventures Ltd (FISCHER) include:What is the dividend yield % of Fischer Medical Ventures Ltd (FISCHER) share?
The current dividend yield of Fischer Medical Ventures Ltd (FISCHER) is 0.10.What is the market cap of Fischer Medical Ventures Ltd (FISCHER) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fischer Medical Ventures Ltd (FISCHER) is ₹3040.24 Cr as of 5th December 2025.What is the 52 week high and low of Fischer Medical Ventures Ltd (FISCHER) share?
The 52-week high of Fischer Medical Ventures Ltd (FISCHER) is ₹124.70 and the 52-week low is ₹40.79.What is the PE and PB ratio of Fischer Medical Ventures Ltd (FISCHER) stock?
The P/E (price-to-earnings) ratio of Fischer Medical Ventures Ltd (FISCHER) is 2040.43. The P/B (price-to-book) ratio is 9.00.Which sector does Fischer Medical Ventures Ltd (FISCHER) belong to?
Fischer Medical Ventures Ltd (FISCHER) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Fischer Medical Ventures Ltd (FISCHER) shares?
You can directly buy Fischer Medical Ventures Ltd (FISCHER) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Fischer Medical Ventures Ltd
FISCHER Share Price
45.922.05% (-0.96)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
FISCHER Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
FISCHER Performance & Key Metrics
FISCHER Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 152.62 | 9.00 | 0.10% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
FISCHER Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
FISCHER Company Profile
Fischer Medical Ventures Ltd manufactures and trades advanced MRI systems with an annual production capacity of 160 units, providing healthcare solutions across multiple medical specialties.
PE Ratio
57.38
57.38
1Y Return
15.01%
15.01%
Buy Reco %
71.43
71.43
POLYMED
PE Ratio
57.21
57.21
1Y Return
33.55%
33.55%
Buy Reco %
66.67
66.67
LAXMIDENTL
PE Ratio
47.65
47.65
1Y Return
49.96%
49.96%
Buy Reco %
100.00
100.00
TARSONS
PE Ratio
40.73
40.73
1Y Return
48.19%
48.19%
Buy Reco %
100.00
100.00
BOROSCI
PE Ratio
40.94
40.94
1Y Return
31.97%
31.97%
Buy Reco %
0.00
0.00
FISCHER Sentiment Analysis
FISCHER Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
FISCHER Stock Summary · November 2025
Fischer Medical Ventures is strategically positioned to capitalize on the transformative shifts in India's healthcare landscape, particularly in diagnostic imaging and preventive healthcare. With a focus on early detection and patient-centric services, the company is enhancing its offerings through innovations like AI-enabled MRI systems and integrated oncology networks, while also expanding production capacity to meet rising demand. Financially, the company has demonstrated impressive growth, with a 118% increase in revenues, supported by a mixed revenue model that balances outright sales and leasing agreements. Despite facing competitive pressures and regulatory challenges, its commitment to affordability and operational efficiency, coupled with strong government support, positions it favorably for sustained growth in both domestic and international markets.
FISCHER Stock Growth Drivers
FISCHER Stock Growth Drivers
6Significant Financial Growth
Fischer Medical Ventures Limited has reported remarkable financial achievements, including a 118% year-on-year increase in
Expansion in Diagnostic Imaging Market
The company is strategically positioned to benefit from the expanding diagnostic imaging market in India,
FISCHER Stock Challenges
FISCHER Stock Challenges
3Regulatory Challenges in International Expansion
The company faces significant hurdles in its efforts to expand internationally due to pending regulatory
Supply Chain and Logistics Issues
There are ongoing concerns regarding supply chain logistics that may impact the company's operational efficiency.
FISCHER Forecast
FISCHER Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
FISCHER
FISCHER
Income
Balance Sheet
Cash Flow
Annual Normal View
FISCHER Income Statement
FISCHER Income Statement
Annual Normal View
| Financial Year | FY 2023 | FY 2024 | FY 2025 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.18 | 21.48 | 112.19 | 181.15 | ||||
Raw Materials | 0.00 | 15.82 | 96.27 | 147.54 | ||||
| Power & Fuel Cost | 0.00 | 0.19 | 0.87 | |||||
| Employee Cost | 0.05 | 0.38 | 2.48 | |||||
| Selling & Administrative Expenses | 0.11 | 1.96 | 10.85 | |||||
| Operating & Other expenses | 0.00 | 0.78 | -2.63 | |||||
EBITDA | 0.02 | 2.35 | 4.35 | 33.61 | ||||
| Depreciation/Amortization | 0.00 | 0.18 | 1.63 | 2.35 | ||||
| PBIT | 0.02 | 2.17 | 2.72 | 31.26 | ||||
| Interest & Other Items | 0.02 | 0.07 | 0.49 | 1.89 | ||||
| PBT | 0.00 | 2.10 | 2.23 | 29.37 | ||||
| Taxes & Other Items | 0.04 | 0.73 | 0.74 | 9.45 | ||||
| Net Income | -0.04 | 1.37 | 1.49 | 19.92 | ||||
| EPS | -0.02 | 0.01 | 0.00 | 0.03 | ||||
| DPS | 0.00 | 0.00 | 0.01 | 0.01 | ||||
| Payout ratio | 0.00 | 0.00 | 1.97 | 0.16 |
FISCHER Company Updates
FISCHER Stock Peers
FISCHER Past Performance & Peer Comparison
FISCHER Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,040.43 | 9.00 | 0.10% |
| Inventurus Knowledge Solutions Ltd | 57.38 | 15.58 | — |
| Poly Medicure Ltd | 57.21 | 7.00 | 0.18% |
| Laxmi Dental Ltd | 47.65 | 7.26 | — |
FISCHER Stock Price Comparison
Compare FISCHER with any stock or ETFCompare FISCHER with any stock or ETF
FISCHER
FISCHER Holdings
FISCHER Shareholdings
FISCHER Promoter Holdings Trend
FISCHER Promoter Holdings Trend
FISCHER Institutional Holdings Trend
FISCHER Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
FISCHER Shareholding Pattern
FISCHER Shareholding Pattern
FISCHER Shareholding History
FISCHER Shareholding History
Foreign Institutions
Mutual Funds Invested in FISCHER
Mutual Funds Invested in FISCHER
No mutual funds holding trends are available
Top 1 Mutual Funds holding Fischer Medical Ventures Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.09% | Change in the portfolio weight of the stock over the last 3 months 0.09% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 82/124 (+26) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing FISCHER stock
smallcases containing FISCHER stock
Looks like this stock is not in any smallcase yet.
FISCHER Events
FISCHER Events
FISCHER Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
FISCHER Dividend Trend
No dividend trend available
FISCHER Upcoming Dividends
FISCHER Upcoming Dividends
No upcoming dividends are available
FISCHER Past Dividends
FISCHER Past Dividends
Cash Dividend
Ex DateEx DateSep 22, 2025
Final
Final | Div/Share: ₹0.01
Dividend/Share
₹0.01
Ex DateEx Date
Sep 22, 2025
FISCHER Stock News & Opinions
FISCHER Stock News & Opinions
Articles & Videos
Corporate
Fischer Medical Ventures arm wins order of Rs 9.29 cr
Time Medical International Ventures (India), the wholly owned subsidiary of Fischer Medical Ventures has been awarded a Rs 9.29 crore order by the Tamil Nadu Animal Husbandry Department for supplying and installing 65 advanced Digital Radiography Units across the state. The project will modernize veterinary diagnostics, enhance animal healthcare, and strengthen diagnostic access in over 60 locations statewide. Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Spotlight
Fischer Medical Ventures Ltd leads losers in 'B' group
Fineotex Chemical Ltd, Blue Jet Healthcare Ltd, G K P Printing & Packaging Ltd and DJ Mediaprint & Logistics Ltd are among the other losers in the BSE's 'B' group today, 04 November 2025.Fischer Medical Ventures Ltd lost 11.52% to Rs 94.85 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 2.75 lakh shares were traded on the counter so far as against the average daily volumes of 1.16 lakh shares in the past one month.Fineotex Chemical Ltd tumbled 11.13% to Rs 28.5. The stock was the second biggest loser in 'B' group.On the BSE, 20.8 lakh shares were traded on the counter so far as against the average daily volumes of 2.25 lakh shares in the past one month.Blue Jet Healthcare Ltd crashed 10.00% to Rs 607.3. The stock was the third biggest loser in 'B' group.On the BSE, 2.47 lakh shares were traded on the counter so far as against the average daily volumes of 22629 shares in the past one month.G K P Printing & Packaging Ltd corrected 9.98% to Rs 9.02. The stock was the fourth biggest loser in 'B' group.On the BSE, 2.11 lakh shares were traded on the counter so far as against the average daily volumes of 57364 shares in the past one month.DJ Mediaprint & Logistics Ltd dropped 8.67% to Rs 82. The stock was the fifth biggest loser in 'B' group.On the BSE, 21152 shares were traded on the counter so far as against the average daily volumes of 2044 shares in the past one month.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Fischer Medical Ventures spurts after strong Q2 performance
Revenue from operations more than doubled to Rs 86.30 crore in September'25 quarter from Rs 39.65 crore recorded in the same period last year. Total expenses for the period under review amounted to Rs 71.48 crore, up 81% YoY. Profit before tax in Q2 FY26 stood at Rs 17.26 crore, which is sharply higher as compared with the pre-tax profit of Rs 0.21 crore posted in Q2 FY25. Fischer Medical Ventures (FMV) is driving a global shift in healthcare through innovative, cost-effective medical imaging and advanced diagnostics. Beyond medical devices, FMV offers a wide range of point-of-care diagnostic solutions. Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Fischer Medical Ventures consolidated net profit rises 4693.10% in the September 2025 quarter
Net profit of Fischer Medical Ventures rose 4693.10% to Rs 13.90 crore in the quarter ended September 2025 as against Rs 0.29 crore during the previous quarter ended September 2024. Sales rose 117.62% to Rs 86.31 crore in the quarter ended September 2025 as against Rs 39.66 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales86.3139.66 118 OPM %18.831.26 - PBDT17.820.67 2560 PBT17.300.38 4453 NP13.900.29 4693 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Fischer Medical Ventures to conduct board meeting
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 28 October 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Fischer Medical Ventures revises Final Dividend
Fischer Medical Ventures, post effectiveness of the Stock Split on 12th September 2025 from Rs.10 per share to Rs.1 per share, has revised the final dividend to Rs.0.005 per share of Rs.1 each. Earlier the board had declared a Dividend of Rs.0.05 per share of Rs.10 each.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Fischer Medical Ventures director resigns
The board of Fischer Medical Ventures at its meeting held on 14 August 2025 has noted the resignation of Dr. Jacob Thomas, Independent Director (DIN: 10639814) with effect from the closing hours of 14 August 2025. Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Fischer Medical Ventures to convene AGM
Fischer Medical Ventures announced that the 32th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Fischer Medical Ventures fixes record date for dividend
Fischer Medical Ventures has fixed 22 September 2025 as record date for purpose of dividend. Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Fischer Medical Ventures reports consolidated net profit of Rs 5.01 crore in the June 2025 quarter
Net profit of Fischer Medical Ventures reported to Rs 5.01 crore in the quarter ended June 2025 as against net loss of Rs 0.12 crore during the previous quarter ended June 2024. Sales rose 131.62% to Rs 23.44 crore in the quarter ended June 2025 as against Rs 10.12 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales23.4410.12 132 OPM %18.13-2.08 - PBDT11.060.40 2665 PBT10.290.13 7815 NP5.01-0.12 LP Powered by Capital Market - Live
3 months agoCapital Market - Live
In last 6 months, promoter holding in the company has decreased by 1.02%
Pledged promoter holdings is insignificant